Chartwell Company Profile
✉ Email this page to a colleague
What is the competitive landscape for CHARTWELL
CHARTWELL has six hundred and thirty-six approved drugs.
There are four tentative approvals on CHARTWELL drugs.
Summary for Chartwell
| US Patents: | 0 |
| Tradenames: | 423 |
| Ingredients: | 397 |
| NDAs: | 636 |
Drugs and US Patents for Chartwell
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chartwell Molecular | CARVEDILOL | carvedilol | TABLET;ORAL | 077474-002 | Sep 5, 2007 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Chartwell Rx | MECLIZINE HYDROCHLORIDE | meclizine hydrochloride | TABLET;ORAL | 203003-001 | Aug 11, 2022 | AA | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Chartwell Molecular | LANIAZID | isoniazid | TABLET;ORAL | 080140-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Chartwell Rx | ECONAZOLE NITRATE | econazole nitrate | CREAM;TOPICAL | 076075-001 | Nov 26, 2002 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Chartwell Rx | METRONIDAZOLE | metronidazole | GEL;TOPICAL | 090903-001 | Jul 22, 2011 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Chartwell Rx | INDOMETHACIN | indomethacin | CAPSULE, EXTENDED RELEASE;ORAL | 200529-001 | Nov 30, 2010 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Chartwell
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Chartwell Rx | MOBAN | molindone hydrochloride | TABLET;ORAL | 017111-007 | Approved Prior to Jan 1, 1982 | 3,491,093 | ⤷ Start Trial |
| Chartwell Rx | LIMBITROL DS | amitriptyline hydrochloride; chlordiazepoxide | TABLET;ORAL | 016949-002 | Approved Prior to Jan 1, 1982 | 4,316,897 | ⤷ Start Trial |
| Chartwell Molecular | MYKROX | metolazone | TABLET;ORAL | 019532-001 | Oct 30, 1987 | 4,517,179 | ⤷ Start Trial |
| Chartwell Rx | MOBAN | molindone hydrochloride | TABLET;ORAL | 017111-008 | Approved Prior to Jan 1, 1982 | 3,491,093 | ⤷ Start Trial |
| Chartwell Rx | LIMBITROL | amitriptyline hydrochloride; chlordiazepoxide | TABLET;ORAL | 016949-001 | Approved Prior to Jan 1, 1982 | 4,316,897 | ⤷ Start Trial |
| Chartwell Rx | VELTIN | clindamycin phosphate; tretinoin | GEL;TOPICAL | 050803-001 | Jul 16, 2010 | 9,492,384 | ⤷ Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
